Skandinaviska Enskilda Banken (SEB)’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-84,900
Closed -$383K 851
2024
Q4
$383K Sell
84,900
-47,500
-36% -$261K ﹤0.01% 728
2024
Q3
$919K Buy
+132,400
New +$1.04M ﹤0.01% 678
2021
Q2
Sell
-27,700
Closed -$1.08M 1081
2021
Q1
$1.08M Sell
27,700
-6,400
-19% -$288K 0.01% 808
2020
Q4
$1.38M Buy
+34,100
New +$1.57M 0.01% 752

Other funds holding GDRX

Skandinaviska Enskilda Banken (SEB)'s GDRX Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 84,900 shares — an estimated $383K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in GDRX in Q4 2020 and held it in 4 quarters. The position peaked at $1.38M in Q4 2020. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 84,900 GoodRx Holdings shares in Q1 2025, an estimated $383K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in GoodRx Holdings in Q4 2020 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s GoodRx Holdings position peaked at $1.38M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.